Rebio Pharma Sàrl
ActiveLimited Liability Company721001 - Research and experimental development in the pharmaceutical industryrebiopharma.com
Biotechnology (Ophthalmology)Patients with ocular oncology conditions, specifically uveal melanoma and retinoblastoma
Rebio Pharma Sàrl is a Swiss GmbH registered in Genève, GE. Its registered activity falls under Research and experimental development in the pharmaceutical industry.
AI-enriched data· marks AI-enriched fields
AI Insight
Registry narrative generated from SHAB/SOGC facts.
Employees~7 employeesRevenue$5.5M in total fundingOfficers3Active Relations3Deleted Relations0SOGC Records1First Record04.09.2025Latest Activity09.09.2025BiotechnologyOphthalmologyOcular OncologyUveal MelanomaTargeted Therapies
Registry Information
c/o address
- Swiss UID
- CHE-198.286.027
- Legal Name
- Rebio Pharma Sàrl
- Legal Form
- Limited liability company
- Incorporated
- 4 Sept 2025
- Share Capital
- 21 parts de CHF 1'000
- Canton
- GE
- Status
- Active
- Country
- Switzerland
Company Purpose
Translating…
NOGA Codes
(Industry classification)Research and experimental development in the pharmaceutical industry
NPROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES72Scientific research and development721Research and experimental development on natural sciences and engineering7210Research and experimental development on natural sciences and engineering721001
Industry Health
Registered Address
Rue du Rhône 114, c/o DEPIGEST SA, Société Fiduciaire, 1204 Genève
1204, Genève, GE
Companies at this address
Enrich from integrations
Pull data from your connected providers and merge it with the registry.
Registry Pulse
Registry pulse is a Pro feature
Current Directors & Officers
From the web
Target Customers
Patients with ocular oncology conditions, specifically uveal melanoma and retinoblastoma
Competitors (4)
Tonix Pharmaceuticals
Tonix Pharmaceuticals, Hovione Farmaciencia, Precision Medicine Group, Brinton Pharmaceuticals
Hovione Farmaciencia
Precision Medicine Group
Brinton Pharmaceuticals
